SALCON BERHAD ("SALCON" OR "THE COMPANY")
PROPOSED ACQUISITION OF 1,020,000 ORDINARY SHARES, REPRESENTING 51% OF THE TOTAL ISSUED SHARES CAPITAL IN JR ENGINEERING AND MEDICAL TECHNOLOGIES (M) SDN BHD BY NUSANTARA JASAKITA SDN BHD (A 90%-OWNED SUBSIDIARY OF SALCON) FROM GANESAN A/L SUBRAMANIAM

We refer to your Company’s announcement dated 12 November 2020, in respect of the aforesaid matter.
In this connection, kindly furnish Bursa Securities with the following additional information for public release:-

1) Whether shareholders’ approval will be sought for Salcon Berhad’s diversification into the glove business pursuant to Paragraph 10.13 of the Main Market Listing Requirements.
2) The total capital and investment outlay to be incurred by JREMT for the additional 12 production lines (“Expansion”), its sources of funding (including the breakdown) and to quantify the portion to be borne by Salcon Berhad and/or NJSB.
3) The current production capacity and output of JREMT and the expected production capacity and output after the Expansion.
Please furnish Bursa Securities with your reply within one (1) market day from the date hereof.

Yours faithfully,
Listing, 
Regulation

Cc : Market Surveillance Dept. , Securities Commission (via fax)